secwatch.observer — SEC 8-K summary
======================================

Issuer:     Foghorn Therapeutics Inc. (FHTX)
CIK:        0001822462
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001628280-25-014136
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Foghorn Therapeutics reduces ATM program capacity from $200M to $100M
---------------------------------------------------------------------

- Amendment No. 1 to Sales Agreement with TD Cowen lowers maximum shares to be sold from $200M to $100M.
- Other terms of the at-the-market offering program remain unchanged; no new public offering announced.
- Amendment effective March 20, 2025; shares sold pursuant to previously effective shelf registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025014136/0001628280-25-014136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822462/000162828025014136/fhtx-20250320.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-014136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer